4chg - Revision history

OCA at 17:46, 7 September 2022

OCA — Wed, 07 Sep 2022 17:46:13 GMT

←Older revision		Revision as of 17:46, 7 September 2022
Line 3:		Line 3:
	<StructureSection load='4chg' size='340' side='right'caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>		<StructureSection load='4chg' size='340' side='right'caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4chg]] is a 10 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Myctu Myctu~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CHG OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4CHG FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4chg]] is a 10 chain structure with sequence from [https://en.wikipedia.org/wiki/Mycobacterium_tuberculosis_H37Rv Mycobacterium tuberculosis H37Rv]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CHG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CHG FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene>, <scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>
-	~~<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat">~~<scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [https://pdbe.org/4chg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [https://www.ebi.ac.uk/pdbsum/4chg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4chg ProSAT]</span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [~~http~~://pdbe.org/4chg PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4chg PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4chg ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[[~~http~~://www.uniprot.org/uniprot/VPC15_MYCTU VPC15_MYCTU]] Toxic component of a toxin-antitoxin (TA) module. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB15.[HAMAP-Rule:MF_00265]<ref>PMID:20011113</ref~~> [[http://www.uniprot.org/uniprot/VPB15_MYCTU VPB15_MYCTU]] Antitoxin component of a toxin-antitoxin (TA) module. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC15.~~	+	[[https://www.uniprot.org/uniprot/VPC15_MYCTU VPC15_MYCTU]] Toxic component of a toxin-antitoxin (TA) module. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB15.[HAMAP-Rule:MF_00265]<ref>PMID:20011113</ref>
-	~~<div style="background-color:#fffaf0;">~~	+
-	~~== Publication Abstract from PubMed ==~~	+
-	Although PIN (PilT N-terminal)-domain proteins are known to have ribonuclease activity, their specific mechanism of action remains unknown. VapCs form a family of ribonucleases that possess a PIN-domain assembly and are known as toxins. The activities of VapCs are impaired by VapB antitoxins. Here we present the crystal structure of the VapBC-15 toxin-antitoxin complex from Mycobacterium tuberculosis determined to 2.1A resolution. The VapB-15 and VapC-15 components assemble into one heterotetramer (VapB2C2) and two heterotrimers (VapBC2) in each asymmetric unit of the crystal. The active site of VapC-15 toxin consists of a cluster of acidic amino acid residues and two divalent metal ions, forming a well organised ribonuclease active site. The distribution of the catalytic-site residues of the VapC-15 toxin is similar to that of T4 RNase H and of Methanococcus jannaschii FEN-1, providing strong evidence that these three proteins share a similar mechanism of activity. The presence of both VapB2C2 and VapBC2 emphasizes the fact that the same antitoxin can bind the toxin in 1:1 and 1:2 ratios. The crystal structure determination of the VapBC-15 complex reveals for the first time a PIN-domain ribonuclease protein that shows two metal ions at the active site and a variable mode of toxin-antitoxin assembly. The structure further shows that VapB-15 antitoxin binds to the same groove meant for the binding of putative substrate (RNA), resulting in the inhibition of VapC-15's toxicity.	+
-		+
-	Crystal structure of the VapBC-15 complex from Mycobacterium tuberculosis reveals a two-metal ion dependent PIN-domain ribonuclease and a variable mode of toxin-antitoxin assembly.,Das U, Pogenberg V, Subhramanyam UK, Wilmanns M, Gourinath S, Srinivasan A J Struct Biol. 2014 Oct 22;188(3):249-258. doi: 10.1016/j.jsb.2014.10.002. PMID:25450593<ref>PMID:25450593</ref>	+
-		+
-	~~From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>~~	+
-	~~</div>~~	+
-	~~<div class="pdbe-citations 4chg" style="background-color:#fffaf0;"></div~~>	+
	== References ==		== References ==
	<references/>		<references/>
Line 24:		Line 14:
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Myctu~~]]	+	[[Category: Mycobacterium tuberculosis H37Rv]]
-	[[Category: Das, U]]	+	[[Category: Das U]]
-	[[Category: Gourinath, S]]	+	[[Category: Gourinath S]]
-	[[Category: Pogenberg, V]]	+	[[Category: Pogenberg V]]
-	[[Category: Srinivasan, A]]	+	[[Category: Srinivasan A]]
-	[[Category: Subhramanyam~~, U K.Tiruttani~~]]	+	[[Category: Tiruttani Subhramanyam UK]]
-	[[Category: Wilmanns, M]]	+	[[Category: Wilmanns M]]
-	~~[[Category: Pin domain]]~~	+
-	~~[[Category: Toxin-antitoxin complex~~]]	+

OCA at 09:54, 5 February 2020

OCA — Wed, 05 Feb 2020 09:54:43 GMT

←Older revision		Revision as of 09:54, 5 February 2020
Line 1:		Line 1:

	==Crystal structure of VapBC15 complex from Mycobacterium tuberculosis==		==Crystal structure of VapBC15 complex from Mycobacterium tuberculosis==
-	<StructureSection load='4chg' size='340' side='right' caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>	+	<StructureSection load='4chg' size='340' side='right'caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4chg]] is a 10 chain structure with sequence from [http://en.wikipedia.org/wiki/Myctu Myctu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CHG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CHG FirstGlance]. <br>		<table><tr><td colspan='2'>[[4chg]] is a 10 chain structure with sequence from [http://en.wikipedia.org/wiki/Myctu Myctu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CHG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CHG FirstGlance]. <br>
Line 23:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Myctu]]		[[Category: Myctu]]
	[[Category: Das, U]]		[[Category: Das, U]]

OCA at 05:47, 8 March 2018

OCA — Thu, 08 Mar 2018 05:47:11 GMT

←Older revision		Revision as of 05:47, 8 March 2018
Line 3:		Line 3:
	<StructureSection load='4chg' size='340' side='right' caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>		<StructureSection load='4chg' size='340' side='right' caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4chg]] is a 10 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CHG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CHG FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4chg]] is a 10 chain structure with sequence from [http://en.wikipedia.org/wiki/Myctu Myctu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CHG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CHG FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>
Line 23:		Line 23:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Myctu]]
	[[Category: Das, U]]		[[Category: Das, U]]
	[[Category: Gourinath, S]]		[[Category: Gourinath, S]]

OCA at 02:15, 5 August 2016

OCA — Fri, 05 Aug 2016 02:15:31 GMT

←Older revision		Revision as of 02:15, 5 August 2016
Line 1:		Line 1:
		+
	==Crystal structure of VapBC15 complex from Mycobacterium tuberculosis==		==Crystal structure of VapBC15 complex from Mycobacterium tuberculosis==
	<StructureSection load='4chg' size='340' side='right' caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>		<StructureSection load='4chg' size='340' side='right' caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>
Line 5:		Line 6:
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [http://www.ebi.ac.uk/pdbsum/4chg PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [http://pdbe.org/4chg PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [http://www.ebi.ac.uk/pdbsum/4chg PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4chg ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 17:		Line 18:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4chg" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 21:57, 24 December 2014

OCA — Wed, 24 Dec 2014 21:57:30 GMT

←Older revision		Revision as of 21:57, 24 December 2014
Line 7:		Line 7:
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [http://www.ebi.ac.uk/pdbsum/4chg PDBsum]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [http://www.ebi.ac.uk/pdbsum/4chg PDBsum]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/VPC15_MYCTU VPC15_MYCTU]] Toxic component of a toxin-antitoxin (TA) module. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB15.[HAMAP-Rule:MF_00265]<ref>PMID:20011113</ref> [[http://www.uniprot.org/uniprot/VPB15_MYCTU VPB15_MYCTU]] Antitoxin component of a toxin-antitoxin (TA) module. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC15.
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==

OCA at 09:45, 17 December 2014

OCA — Wed, 17 Dec 2014 09:45:31 GMT

←Older revision		Revision as of 09:45, 17 December 2014
Line 7:		Line 7:
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [http://www.ebi.ac.uk/pdbsum/4chg PDBsum]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [http://www.ebi.ac.uk/pdbsum/4chg PDBsum]</span></td></tr>
	</table>		</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Although PIN (PilT N-terminal)-domain proteins are known to have ribonuclease activity, their specific mechanism of action remains unknown. VapCs form a family of ribonucleases that possess a PIN-domain assembly and are known as toxins. The activities of VapCs are impaired by VapB antitoxins. Here we present the crystal structure of the VapBC-15 toxin-antitoxin complex from Mycobacterium tuberculosis determined to 2.1A resolution. The VapB-15 and VapC-15 components assemble into one heterotetramer (VapB2C2) and two heterotrimers (VapBC2) in each asymmetric unit of the crystal. The active site of VapC-15 toxin consists of a cluster of acidic amino acid residues and two divalent metal ions, forming a well organised ribonuclease active site. The distribution of the catalytic-site residues of the VapC-15 toxin is similar to that of T4 RNase H and of Methanococcus jannaschii FEN-1, providing strong evidence that these three proteins share a similar mechanism of activity. The presence of both VapB2C2 and VapBC2 emphasizes the fact that the same antitoxin can bind the toxin in 1:1 and 1:2 ratios. The crystal structure determination of the VapBC-15 complex reveals for the first time a PIN-domain ribonuclease protein that shows two metal ions at the active site and a variable mode of toxin-antitoxin assembly. The structure further shows that VapB-15 antitoxin binds to the same groove meant for the binding of putative substrate (RNA), resulting in the inhibition of VapC-15's toxicity.
		+
		+	Crystal structure of the VapBC-15 complex from Mycobacterium tuberculosis reveals a two-metal ion dependent PIN-domain ribonuclease and a variable mode of toxin-antitoxin assembly.,Das U, Pogenberg V, Subhramanyam UK, Wilmanns M, Gourinath S, Srinivasan A J Struct Biol. 2014 Oct 22;188(3):249-258. doi: 10.1016/j.jsb.2014.10.002. PMID:25450593<ref>PMID:25450593</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>

OCA at 06:50, 12 November 2014

OCA — Wed, 12 Nov 2014 06:50:22 GMT

←Older revision		Revision as of 06:50, 12 November 2014
Line 1:		Line 1:
-	'''~~Unreleased structure~~'''	+	==Crystal structure of VapBC15 complex from Mycobacterium tuberculosis==
-		+	<StructureSection load='4chg' size='340' side='right' caption='[[4chg]], [[Resolution\|resolution]] 2.10Å' scene=''>
-	~~The entry~~ 4chg is ~~ON HOLD until Paper Publication~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4chg]] is a 10 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CHG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CHG FirstGlance]. <br>
-	~~Authors~~: Das, U., Pogenberg, V., ~~Tiruttani~~ Subhramanyam, U.K., Wilmanns, M~~., Srinivasan, A., Gourinath, S.~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MN:MANGANESE+(II)+ION'>MN</scene></td></tr>
-		+	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr>
-	~~Description~~: ~~Crystal structure of VapBC15~~ complex ~~from Mycobacterium tuberculosis~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4chg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4chg OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4chg RCSB], [http://www.ebi.ac.uk/pdbsum/4chg PDBsum]</span></td></tr>
		+	</table>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Das, U]]
		+	[[Category: Gourinath, S]]
		+	[[Category: Pogenberg, V]]
		+	[[Category: Srinivasan, A]]
		+	[[Category: Subhramanyam, U K.Tiruttani]]
		+	[[Category: Wilmanns, M]]
		+	[[Category: Pin domain]]
		+	[[Category: Toxin-antitoxin complex]]

OCA: Protected "4chg" [edit=sysop:move=sysop]

OCA — Wed, 11 Dec 2013 12:47:38 GMT

Protected "4chg" [edit=sysop:move=sysop]

←Older revision

Revision as of 12:47, 11 December 2013

OCA: New page: '''Unreleased structure''' The entry 4chg is ON HOLD until Paper Publication Authors: Das, U., Pogenberg, V., Tiruttani Subhramanyam, U.K., Wilmanns, M., Srinivasan, A., Gourinath, S. ...

OCA — Wed, 11 Dec 2013 12:47:37 GMT

New page: '''Unreleased structure''' The entry 4chg is ON HOLD until Paper Publication Authors: Das, U., Pogenberg, V., Tiruttani Subhramanyam, U.K., Wilmanns, M., Srinivasan, A., Gourinath, S. ...

New page

'''Unreleased structure'''

The entry 4chg is ON HOLD until Paper Publication

Authors: Das, U., Pogenberg, V., Tiruttani Subhramanyam, U.K., Wilmanns, M., Srinivasan, A., Gourinath, S.

Description: Crystal structure of VapBC15 complex from Mycobacterium tuberculosis